Rita Raddatz

2.5k total citations · 1 hit paper
42 papers, 1.7k citations indexed

About

Rita Raddatz is a scholar working on Molecular Biology, Immunology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Rita Raddatz has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 22 papers in Immunology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in Rita Raddatz's work include Receptor Mechanisms and Signaling (31 papers), Mast cells and histamine (22 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Rita Raddatz is often cited by papers focused on Receptor Mechanisms and Signaling (31 papers), Mast cells and histamine (22 papers) and Neurotransmitter Receptor Influence on Behavior (7 papers). Rita Raddatz collaborates with scholars based in United States, France and Spain. Rita Raddatz's co-authors include Stephen M. Lanier, Robert L. Hudkins, Roman Artymyshyn, James A. Bonini, Theresa A. Branchek, Evguenia Kouranova, Christophe Gerald, Nika Adham, Beth Borowsky and Angelo Parini and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Annals of the New York Academy of Sciences.

In The Last Decade

Rita Raddatz

40 papers receiving 1.6k citations

Hit Papers

Trace amines: Identification of a family of mammalian G p... 2001 2026 2009 2017 2001 200 400 600

Peers

Rita Raddatz
Joanne R. Mathiasen United States
Kemal Payza United States
Laura R. Fitzgerald United States
Purnima Deshpande United States
Ann E. Kingston United States
Lisa M. Broad United Kingdom
Rita Raddatz
Citations per year, relative to Rita Raddatz Rita Raddatz (= 1×) peers Karin Rimvall

Countries citing papers authored by Rita Raddatz

Since Specialization
Citations

This map shows the geographic impact of Rita Raddatz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rita Raddatz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rita Raddatz more than expected).

Fields of papers citing papers by Rita Raddatz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rita Raddatz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rita Raddatz. The network helps show where Rita Raddatz may publish in the future.

Co-authorship network of co-authors of Rita Raddatz

This figure shows the co-authorship network connecting the top 25 collaborators of Rita Raddatz. A scholar is included among the top collaborators of Rita Raddatz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rita Raddatz. Rita Raddatz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hudkins, Robert L., Lisa D. Aimone, Mark A. Olsen, et al.. (2015). 3,4-Diaza-bicyclo[4.1.0]hept-4-en-2-one phenoxypropylamine analogs of irdabisant (CEP-26401) as potent histamine-3 receptor inverse agonists with robust wake-promoting activity. European Journal of Medicinal Chemistry. 95. 349–356. 9 indexed citations
2.
Josef, Kurt A., et al.. (2012). Synthesis of constrained benzocinnolinone analogues of CEP-26401 (irdabisant) as potent, selective histamine H3 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 22(12). 4198–4202. 6 indexed citations
3.
Bailey, T. R., Derek Dunn, Sankar Chatterjee, et al.. (2012). Novel morpholine ketone analogs as potent histamine H3 receptor inverse agonists with wake activity. Bioorganic & Medicinal Chemistry Letters. 22(4). 1546–1549. 5 indexed citations
4.
Aimone, Lisa D., et al.. (2012). Synthesis and evaluation of 4- and 5-pyridazin-3-one phenoxypropylamine analogues as histamine-3 receptor antagonists. Bioorganic & Medicinal Chemistry. 20(12). 3880–3886. 7 indexed citations
5.
Raddatz, Rita, Robert L. Hudkins, Joanne R. Mathiasen, et al.. (2011). CEP-26401 (Irdabisant), a Potent and Selective Histamine H3 Receptor Antagonist/Inverse Agonist with Cognition-Enhancing and Wake-Promoting Activities. Journal of Pharmacology and Experimental Therapeutics. 340(1). 124–133. 52 indexed citations
6.
Aimone, Lisa D., et al.. (2011). Synthesis and evaluation of 4-alkoxy-[1′-cyclobutyl-spiro(3,4-dihydrobenzopyran-2,4′-piperidine)] analogues as histamine-3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 22(1). 186–189. 13 indexed citations
7.
Hudkins, Robert L., Lisa D. Aimone, T. R. Bailey, et al.. (2011). Identification of pyridazin-3-one derivatives as potent, selective histamine H3 receptor inverse agonists with robust wake activity. Bioorganic & Medicinal Chemistry Letters. 21(18). 5493–5497. 18 indexed citations
8.
Tao, Ming, Rita Raddatz, Lisa D. Aimone, & Robert L. Hudkins. (2011). Synthesis and structure–activity relationships of 4,5-fused pyridazinones as histamine H3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(20). 6126–6130. 16 indexed citations
9.
Tao, Ming, Lisa D. Aimone, John A. Gruner, et al.. (2011). Synthesis and structure–activity relationship of 5-pyridazin-3-one phenoxypiperidines as potent, selective histamine H3 receptor inverse agonists. Bioorganic & Medicinal Chemistry Letters. 22(2). 1073–1077. 15 indexed citations
10.
Raddatz, Rita, Ming Tao, & Robert L. Hudkins. (2010). Histamine H3 Antagonists for Treatment of Cognitive Deficits in CNS Diseases. Current Topics in Medicinal Chemistry. 10(2). 153–169. 70 indexed citations
11.
Raddatz, Rita, Hervé Schaffhauser, & Michael J. Marino. (2007). Allosteric approaches to the targeting of G-protein-coupled receptors for novel drug discovery: A critical assessment. Biochemical Pharmacology. 74(3). 383–391. 28 indexed citations
12.
Raddatz, Rita, Roman Artymyshyn, James A. Bonini, et al.. (2000). Identification and Characterization of Two Neuromedin U Receptors Differentially Expressed in Peripheral Tissues and the Central Nervous System. Journal of Biological Chemistry. 275(42). 32452–32459. 170 indexed citations
13.
Raddatz, Rita, et al.. (1999). Imidazoline Binding Domains on MAO‐B: Localization and Accessibilitya. Annals of the New York Academy of Sciences. 881(1). 26–31. 8 indexed citations
14.
Raddatz, Rita & Stephen M. Lanier. (1997). Relationship between imidazoline/guanidinium receptive sites and monoamine oxidase A and B. Neurochemistry International. 30(1). 109–117. 19 indexed citations
15.
Lanier, Stephen M., Rita Raddatz, & Angelo Parini. (1997). Relationship between α2-Adrenergic Receptors and Imidazoline/Guanidinium Receptive Sites. Advances in pharmacology. 42. 474–477. 2 indexed citations
16.
Raddatz, Rita, et al.. (1995). Structural and ligand recognition properties of imidazoline binding proteins in tissues of rat and rabbit.. Molecular Pharmacology. 48(4). 703–710. 23 indexed citations
17.
Krause, James E., Y. Takeda, Paul Blount, et al.. (1993). Structure, expression and second messenger-mediated regulation of the human and rat substance P receptors and their genes. Regulatory Peptides. 46(1-2). 59–66. 21 indexed citations
19.
Doherty, Niall S., et al.. (1991). S-Adenosylhomocysteine Levels Are Not Involved in the Spasmolytic Activity of 3-Deazaadenosine in Guinea-Pig Lung Parenchyma. Pharmacology. 42(3). 151–155. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026